JOSEPH A SPARANO, MD
Osteopathic Medicine at Eastchester Rd, Bronx, NY
License number
New York 161242
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
2
1695 Eastchester Rd, Bronx, NY 10461
172 Edgewood Ave, Pleasantville, NY 10570
172 Edgewood Ave, Pleasantville, NY 10570
Phone
(718) 405-8505
(718) 904-2830 (Fax)
(718) 904-2830 (Fax)
Organization information
See more information about JOSEPH A SPARANO at bizstanding.comJoseph Sparano MD
1825 Eastchester Rd, Bronx, NY 10461
Industry:
Internist
Phone:
(718) 904-2000 (Phone)
Joseph Anthony Sparano
Professional information
Dr. Joseph A Sparano, Bronx NY - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
Montefiore Medical Center ONC
1695 Eastchester Rd, Bronx 10461
(718) 405-8505 (Phone)
1695 Eastchester Rd, Bronx 10461
(718) 405-8505 (Phone)
Certifications:
Internal Medicine, 1986, Medical Oncology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Montefiore Medical Center ONC
1695 Eastchester Rd, Bronx 10461
Montefiore Medical Center
111 East 210Th St, Bronx 10467
1695 Eastchester Rd, Bronx 10461
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Education:
Medical School
New York Medical College
Graduated: 1982
St Vincents Hospital Med Center
Graduated: 1983
Graduated: 1986
Montefiore Med Center
Graduated: 1988
New York Medical College
Graduated: 1982
St Vincents Hospital Med Center
Graduated: 1983
Graduated: 1986
Montefiore Med Center
Graduated: 1988
Joseph A Sparano, Bronx NY
Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology, Hematology
Work:
Montefiore Medical Center
1695 Eastchester Rd, Bronx, NY 10461 Montefiore Medical Center
1825 Eastchester Rd, Bronx, NY 10461 Montefiore Medical Center
111 E 210Th St, Bronx, NY 10467
1695 Eastchester Rd, Bronx, NY 10461 Montefiore Medical Center
1825 Eastchester Rd, Bronx, NY 10461 Montefiore Medical Center
111 E 210Th St, Bronx, NY 10467
Education:
New York Medical College (1982)
Gene Expression Markers Of Recurrence Risk In Cancer Patients After Chemotherapy
US Patent:
2009012, May 14, 2009
Filed:
Aug 15, 2008
Appl. No.:
12/192825
Inventors:
JOFFRE BAKER - Montara CA, US
Robert Gray - Boston MA, US
Steven Shak - Hillsborough CA, US
Joseph Sparano - Pleasantville NY, US
Carl Yoshizawa - Redwood City CA, US
Robert Gray - Boston MA, US
Steven Shak - Hillsborough CA, US
Joseph Sparano - Pleasantville NY, US
Carl Yoshizawa - Redwood City CA, US
International Classification:
G01N 33/48, C12Q 1/68, G06F 19/00
US Classification:
702 20, 435 6
Abstract:
The present invention relates to genes, the expression levels of which are correlated with likelihood of breast cancer recurrence in patients after tumor resection and chemotherapy.
Tests To Predict Responsiveness Of Cancer Patients To Chemotherapy Treatment Options
US Patent:
2009031, Dec 17, 2009
Filed:
May 12, 2009
Appl. No.:
12/464797
Inventors:
STEVE SHAK - REDWOOD CITY CA, US
JOFFRE B. BAKER - MONTARA CA, US
CARL YOSHIZAWA - REDWOOD CITY CA, US
JOSEPH SPARANO - PLEASANTVILLE NY, US
ROBERT GRAY - BOSTON MA, US
JOFFRE B. BAKER - MONTARA CA, US
CARL YOSHIZAWA - REDWOOD CITY CA, US
JOSEPH SPARANO - PLEASANTVILLE NY, US
ROBERT GRAY - BOSTON MA, US
International Classification:
C12Q 1/68, C12Q 1/02, G01N 1/30
US Classification:
435 6, 435 29, 435 4052
Abstract:
The present disclosure provides methods and compositions to facilitate prediction of the likelihood of responsiveness of cancer patients to treatment including a taxane and/or a cyclophosphamide.
Gene Expression Markers Of Recurrence Risk In Cancer Patients After Chemotherapy
US Patent:
2011017, Jul 14, 2011
Filed:
Oct 7, 2010
Appl. No.:
12/900388
Inventors:
JOFFRE BAKER - MONTARA CA, US
ROBERT GRAY - BOSTON MA, US
STEVEN SHAK - HILLSBOROUGH CA, US
JOSEPH SPARANO - PLEASANTVILLE NY, US
CARL YOSHIZAWA - REDWOOD CITY CA, US
ROBERT GRAY - BOSTON MA, US
STEVEN SHAK - HILLSBOROUGH CA, US
JOSEPH SPARANO - PLEASANTVILLE NY, US
CARL YOSHIZAWA - REDWOOD CITY CA, US
International Classification:
C12Q 1/68
US Classification:
435 611, 435 613, 435 612
Abstract:
The present invention relates to genes, the expression levels of which are correlated with likelihood of breast cancer recurrence in patients after tumor resection and chemotherapy.
Method For Determining The Likelihood Of Response To Her2 Inhibitors
US Patent:
2010015, Jun 17, 2010
Filed:
Sep 4, 2009
Appl. No.:
12/554783
Inventors:
Frederick L. Baehner - San Francisco CA, US
Drew Watson - Los Altos CA, US
Tara Maddala - Redwood City CA, US
Steve Shak - Hillsborough CA, US
Robert Gray - Boston MA, US
Joseph Sparano - Pleasantville NY, US
Drew Watson - Los Altos CA, US
Tara Maddala - Redwood City CA, US
Steve Shak - Hillsborough CA, US
Robert Gray - Boston MA, US
Joseph Sparano - Pleasantville NY, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present disclosure provides methods for determining the HER2 Status of a cancer tumor sample.